PATENT
Employment Agreement Is Valid Proof of Right: Delhi High Court Sets Aside Patent Rejection After Inventor's Death
The Delhi High Court has set aside a Patent Office order that refused a patent application filed by Nippon Steel Corporation for a “high-strength steel sheet and its manufacturing method.” The court held that the Patent Office wrongly rejected the application on the ground that Nippon Steel had failed to establish “proof of right.” It also found fault with the Patent Office's view that an employment agreement could not serve as valid proof of such a right.Proof of right refers to documents...
Delhi High Court Refuses To Restrain Haryana Company From Making Foldable Display Units In Patent Row
The Delhi High Court has declined to stop a rival manufacturer from making and selling foldable display units, saying the patent holder did not make out a case for interim protection. A single bench of Justice Mini Pushkarna, in a judgment delivered on December 24, 2025, dismissed a plea filed by the inventor Amitoje India Private Limited, a Delhi company against Haryana based Classic Display Systems Private Limited. The court held that the company's patent faced a credible challenge on...
Delhi High Court Revives Inventor's Patent Application For Mechanical Folding Device
The Delhi High Court has set aside a Patent Office order refusing a patent application filed by inventor Resham Priyadarshini for an invention titled “A Device For Folding Or Bending An Article”. The court held that the rejection was based on an incomplete reading of the application and remanded the matter for fresh consideration.In a judgment dated December 24, 2025, a single-judge Bench of Justice Manmeet Pritam Singh Arora held that the Patent Office wrongly concluded that the claims were...
Madras High Court Grants Inventor Opportunity To Demonstrate His Solar Power Device Before Patent Office
The Madras High Court has directed the Patent Office to grant an inventor one opportunity to demonstrate the working of his invention, holding that a potentially viable invention should not be rejected without adequate consideration.Justice N Anand Venkatesh passed the order on December 18, 2025, while disposing of a writ petition filed by Kannan Gopalakrishnan challenging the rejection of his patent review application relating to an invention titled “Solar Supplemental Power Source.” The...
Intellectual Property Rights Weekly Round-Up: December 15-21, 2025
NOMINAL INDEXDPIIT Working Paper on Generative AI and CopyrightFrankfinn Aviation Services (Pvt.) Ltd. v. M/S Fly High Institute & Ors., 2025 LiveLaw (Del) 1713Lifestyle Equities C.V. & Anr. v. Priyanka Alpeshbhai Polara, 2025 LiveLaw (Del) 1715Au Naturel Beauty Private Limited v. Wet and Dry Personal Care Pvt. Ltd. & Anr., 2025 LiveLaw (Del) 1716Bhavesh Suresh Kataria v. Kataria Insurance Brokers Pvt. Ltd., IA No. 1663/2021 in Commercial IP Suit No. 215/2021Mandeep Singh v. Shabir...
Commercial Courts Act Bars Intra-Court Appeals In Patent Disputes: Madras High Court
The Madras High Court has held that an intra-court appeal is not maintainable against an order passed by a Single Judge while deciding a statutory patent appeal under the Patents Act. The court reiterated that the Commercial Courts Act does not permit a second appeal within the High Court. “Any expansion of scope of the Commercial Courts Act will defeat its objectives and there is no ambiguity regarding appeals from decrees of Commercial Courts and Commercial Divisions under Section 13 of the...
Delhi High Court Refuses To Stay Order Allowing Dr. Reddy's To Manufacture And Export Semaglutide
The Delhi High Court on Friday refused Danish drug maker Novo Nordisk's plea for an immediate ex-parte stay on a single judge's order that allowed Dr. Reddy's Laboratories to manufacture and export Semaglutide-based formulations to countries where Novo Nordisk does not hold patent rights. A Division Bench of Justice C Hari Shankar and Justice Om Prakash Shukla, while hearing Novo Nordisk's application for interim relief in its appeal, noted that the single judge had not rejected Novo Nordisk's...
After Dr Reddy's, Sun Pharma Commits To Not Selling Semaglutide In India Till March 2026
The Delhi High Court on Wednesday recorded Sun Pharmaceutical Industries Ltd.'s assurance that it will not sell its semaglutide-based drug in India until March 20, 2026, when Danish drugmaker Novo Nordisk's patent expires. Appearing before Justice Manmeet Pritam Singh Arora, the company also committed to exporting the drug only to countries where Novo does not hold patent rights. Subsequently, it allowed Sun Pharma to export its semaglutide preparations outside the country. This...
Madras High Court Orders Fresh Review of TVS Motor's Patent Plea For Scooter Frame Design
The Madras High Court has overturned a decision by the Patent Office that had denied TVS Motor Company a patent for its "vehicle frame assembly" invention. The court said the Patent Office did not properly examine how the design worked or whether it was truly obvious from earlier technologies.In its ruling dated November 28, 2025, Justice Senthilkumar Ramamoorthy said the refusal order did not provide enough reasoning to conclude that TVS Motor's invention lacked originality. Because the...
LiveLawBiz: Business Law Daily Round-Up: December 02, 2025
TAX AssessmentOrder Passed Without Awaiting DVD Report Violates S. 50C(2) IncomeTax Act: ITAT Ahmedabad 'WritNot Maintainable In Face Of Disputed Ownership': Delhi High Court InCustoms Gold Confiscation Case S.153C Income Tax Act | Public Info, Unrelated Data Seized FromSearched Person Not Enough To Issue Show Cause Notice: Gujarat HighCourt IncomeTax Act | S. 153C Proceedings Unsustainable Without IncriminatingMaterial Found In Search: Calcutta High Court AdmissionSolutions By TC Global...
Delhi High Court Upholds Rejection Of Patent For Amylin and AstraZeneca's Sustained-Release Diabetes Injection
The Delhi High Court has upheld the Patent Office's refusal to grant Amylin Pharmaceuticals and AstraZeneca Pharmaceuticals a patent for their sustained-release exenatide injection for diabetes, ruling that the formulation was 'obvious' from existing science and lacked the inventive step required for protection. A single bench of Justice Tejas Karia in an order dated November 24 said that the formulation would be obvious to a skilled person, reading the earlier scientific disclosures, "obvious...
Centre Revamps Patent Penalty Rules; Appeal Period Now Begins On Receipt Of Order Instead of Date Of Order
The Centre government has overhauled the penalty adjudication mechanism under the Patents Rules, 2003 after notifying the Patents (Amendment) Rules, 2025, which came into force on November 25, 2025. The amendment substitutes the entire Chapter XIV A -Adjudictaion Of Penalties and Appeals, that had been introduced in 2024 and introduces several procedural changes while retaining the structure of the earlier framework.The most significant change is that the 60 day period for filing an appeal...